883 related articles for article (PubMed ID: 24106319)
1. C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia.
Porfyridis I; Georgiadis G; Vogazianos P; Mitis G; Georgiou A
Respir Care; 2014 Apr; 59(4):574-81. PubMed ID: 24106319
[TBL] [Abstract][Full Text] [Related]
2. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
Ugajin M; Yamaki K; Hirasawa N; Yagi T
Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
[TBL] [Abstract][Full Text] [Related]
3. Carboxy-terminal provasopressin may predict prognosis in nursing home acquired pneumonia.
Kim SH; Chung JH; Lee JC; Park YH; Joe JH; Hwang HJ
Clin Chim Acta; 2013 Jun; 421():226-9. PubMed ID: 23454473
[TBL] [Abstract][Full Text] [Related]
4. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia.
Ramirez P; Garcia MA; Ferrer M; Aznar J; Valencia M; Sahuquillo JM; Menéndez R; Asenjo MA; Torres A
Eur Respir J; 2008 Feb; 31(2):356-62. PubMed ID: 17959634
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of prognostic factors in hospitalized patients with pneumonia occurring outside hospital: Serum albumin is not less important than pneumonia severity assessment scale.
Miyazaki H; Nagata N; Akagi T; Takeda S; Harada T; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Fujita M; Watanabe K
J Infect Chemother; 2018 Aug; 24(8):602-609. PubMed ID: 29628384
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of severity indicators of nursing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients.
Ugajin M; Yamaki K; Hirasawa N; Kobayashi T; Yagi T
Clin Interv Aging; 2014; 9():267-74. PubMed ID: 24611004
[TBL] [Abstract][Full Text] [Related]
7. The value of procalcitonin level in community-acquired pneumonia in the ED.
Park JH; Wee JH; Choi SP; Oh SH
Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M
Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of nursing home-acquired pneumonia in elderly patients admitted to a Korean teaching hospital.
Koh SJ; Lee JH
Korean J Intern Med; 2015 Sep; 30(5):638-47. PubMed ID: 26354058
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
[TBL] [Abstract][Full Text] [Related]
11. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
[TBL] [Abstract][Full Text] [Related]
12. Validity of severity scores in hospitalized patients with nursing home-acquired pneumonia.
El-Solh AA; Alhajhusain A; Abou Jaoude P; Drinka P
Chest; 2010 Dec; 138(6):1371-6. PubMed ID: 20507947
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of procalcitonin in community-acquired pneumonia.
Schuetz P; Suter-Widmer I; Chaudri A; Christ-Crain M; Zimmerli W; Mueller B;
Eur Respir J; 2011 Feb; 37(2):384-92. PubMed ID: 20595156
[TBL] [Abstract][Full Text] [Related]
14. Significance of blood cultures in nursing home-acquired pneumonia.
Yamazoe M; Tomioka H; Yamashita S; Furuta K; Kaneko M
J Infect Chemother; 2018 Apr; 24(4):272-277. PubMed ID: 29292179
[TBL] [Abstract][Full Text] [Related]
15. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
[TBL] [Abstract][Full Text] [Related]
16. The association of serum procalcitonin and high-sensitivity C-reactive protein with pneumonia in elderly multimorbid patients with respiratory symptoms: retrospective cohort study.
Nouvenne A; Ticinesi A; Folesani G; Cerundolo N; Prati B; Morelli I; Guida L; Lauretani F; Maggio M; Aloe R; Lippi G; Meschi T
BMC Geriatr; 2016 Jan; 16():16. PubMed ID: 26772604
[TBL] [Abstract][Full Text] [Related]
17. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology.
Bello S; Lasierra AB; Mincholé E; Fandos S; Ruiz MA; Vera E; de Pablo F; Ferrer M; Menendez R; Torres A
Eur Respir J; 2012 May; 39(5):1144-55. PubMed ID: 22075489
[TBL] [Abstract][Full Text] [Related]
18. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
[TBL] [Abstract][Full Text] [Related]
19. Outcome of nursing home-acquired pneumonia: derivation and application of a practical model to predict 30 day mortality.
Naughton BJ; Mylotte JM; Tayara A
J Am Geriatr Soc; 2000 Oct; 48(10):1292-9. PubMed ID: 11037018
[TBL] [Abstract][Full Text] [Related]
20. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
